Sun et al. discovered that phosphorylating GLUT1 enhances glycolytic activity of the CAFs in breast cancer to promote cancer-cell invasion by activating the TGFβ1/p38 MAPK/MMP2/9 signaling axis [57]. The gene discussed is TGFB1; the disease is breast carcinoma.